Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab.
Chin, S.M., Kimberlin, C.R., Roe-Zurz, Z., Zhang, P., Xu, A., Liao-Chan, S., Sen, D., Nager, A.R., Oakdale, N.S., Brown, C., Wang, F., Yang, Y., Lindquist, K., Yeung, Y.A., Salek-Ardakani, S., Chaparro-Riggers, J.(2018) Nat Commun 9: 4679-4679
- PubMed: 30410017 
- DOI: 10.1038/s41467-018-07136-7
- Primary Citation of Related Structures:  
6MGE, 6MHR, 6MI2 - PubMed Abstract: 
4-1BB (CD137, TNFRSF9) is an inducible costimulatory receptor expressed on activated T cells. Clinical trials of two agonist antibodies, utomilumab (PF-05082566) and urelumab (BMS-663513), are ongoing in multiple cancer indications, and both antibodies demonstrate distinct activities in the clinic ...